Lerouge, L.; Gries, M.; Chateau, A.; Daouk, J.; Lux, F.; Rocchi, P.; Cedervall, J.; Olsson, A.-K.; Tillement, O.; Frochot, C.;
et al. Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles. Pharmaceutics 2023, 15, 997.
https://doi.org/10.3390/pharmaceutics15030997
AMA Style
Lerouge L, Gries M, Chateau A, Daouk J, Lux F, Rocchi P, Cedervall J, Olsson A-K, Tillement O, Frochot C,
et al. Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles. Pharmaceutics. 2023; 15(3):997.
https://doi.org/10.3390/pharmaceutics15030997
Chicago/Turabian Style
Lerouge, Lucie, Mickaël Gries, Alicia Chateau, Joël Daouk, François Lux, Paul Rocchi, Jessica Cedervall, Anna-Karin Olsson, Olivier Tillement, Céline Frochot,
and et al. 2023. "Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles" Pharmaceutics 15, no. 3: 997.
https://doi.org/10.3390/pharmaceutics15030997
APA Style
Lerouge, L., Gries, M., Chateau, A., Daouk, J., Lux, F., Rocchi, P., Cedervall, J., Olsson, A.-K., Tillement, O., Frochot, C., Acherar, S., Thomas, N., & Barberi-Heyob, M.
(2023). Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX®-Design Nanoparticles. Pharmaceutics, 15(3), 997.
https://doi.org/10.3390/pharmaceutics15030997